Latisse is no longer registered in Australia. Its ARTG entry for bimatoprost was cancelled in 2017. Lumigan is a separately registered bimatoprost eye medicine; this does not make it an approved lash-growth product. Whether a medicine is appropriate for an individual is a clinician's decision. This guide compares prescription bimatoprost with non-prescription lash serums using product-specific evidence, ingredient lists, directions, possible adverse effects and current costs.
What is Latisse, and what is its status in Australia?
Latisse was a 0.03% bimatoprost solution studied for eyelash hypotrichosis. The TGA's assessment records its former registration, cancellation and clinical evidence of eyelash growth, alongside eye and skin adverse effects. Other bimatoprost eye medicines have different registered uses; a clinician can explain prescription options, suitability and monitoring. Do not substitute a cosmetic conditioning serum for a prescribed treatment, or assume that one medicine's trial results apply to another product.
Head to head
| Latisse (bimatoprost) | Non-prescription serums listing prostaglandin analogues | Prostaglandin-free cosmetic serums | |
|---|---|---|---|
| Purpose | Bimatoprost was studied for eyelash growth | Check each product's ingredient list, claims and evidence | Cosmetic conditioning of existing lashes; formulas differ |
| Visible results | Studied in clinical trials; individual response varies | No category-wide timeline; check finished-product evidence | No category-wide timeline; check finished-product evidence |
| Safety | Eye and skin adverse effects documented in the TGA assessment | Review each formula's safety information and seek professional advice if unsure | The absence of a listed prostaglandin analogue does not rule out irritation or individual sensitivity |
| Australian status | Latisse is no longer ARTG-registered; ask a clinician about current prescription options | Check the specific product's status and claims | Check the complete product information and directions |
| Cost | Medicine, consultation and follow-up costs vary | Compare current price, pack size, directions and delivery | Compare current price, pack size, directions and delivery |
| If you stop | Loss of response after stopping bimatoprost is discussed in the TGA assessment | Do not assume a category-wide pattern | Do not assume a category-wide pattern |
How should you compare the options?
- Discuss prescription treatment with a clinician if lash growth rather than cosmetic conditioning is your goal. Ask about evidence, adverse effects, suitability and follow-up.
- Review any non-prescription serum by checking its complete ingredient list, intended use, product-specific evidence and directions. A category label alone does not establish safety or expected results.
- Consider cosmetic conditioning if your aim is to care for the appearance of existing lashes. The LashOriginals Lash Serum contains peptides, biotin and panthenol and is intended for a fuller-looking appearance; it is not a lash-growth medicine. If you have sensitive eyes or use contacts or extensions, check its ingredients and directions with an eye-care professional or lash technician rather than assuming compatibility.
Compare product-specific evidence, complete ingredients, directions, possible adverse effects and current total cost. Prescription decisions belong with a clinician; a cosmetic serum is not a substitute for medical treatment.
General information only — talk to your GP about prescription options.
Browse: our prostaglandin-free lash range.
Related reading
- Brow serums in Australia, compared
- Prostaglandin Lash Serum Side Effects
- How to Choose the Best Eyelash Serum in Australia (2026)
Sources
- Therapeutic Goods Administration (TGA) — Determining if your product is a cosmetic or therapeutic good
- Therapeutic Goods Administration (TGA) — Latisse bimatoprost assessment and registration history
- Therapeutic Goods Administration (TGA) — Lumigan ARTG entry
Written by the Lash Originals Editorial Team · Reviewed 7 September 2026. This article is general cosmetic information, not medical advice.